Iran Started Producing The Russian Sputnik V Vaccine

Iran has started producing the Russian Sputnik V vaccine. The vaccine is produced in the country under license from the Russian Gamaleya Institute.

Iran has announced that it has started to produce the Sputnik V vaccine developed by Russia against the coronavirus (Covid-19) domestically under the license of the Russian Gamaleya Institute. According to the news of the Iranian state television, the first samples of the Sputnik V vaccine, produced by the pharmaceutical company Actover Group in Tehran, were used for publicity at a ceremony attended by the Minister of Health Said Nemeki. It was stated that 2 million doses of Sputnik V vaccine per month will be produced at the production facilities of Actover Group, located in the Baharistan Industrial Complex in the northwest of Tehran, under the license of the Russian Gamaleya Institute. In Iran, Russia's Sputnik V vaccine was authorized for emergency use on January 26, and the first shipment of the vaccine entered Tehran on February 4. Iran's Ambassador to Moscow Kazim Celali announced on February 10 that they had reached an agreement with Russia on the production of Sputnik V vaccines in Iran. In Iran, where the vaccination campaign was launched on February 9, approximately 6 million doses of vaccine have been administered so far. The Ministry of Health of Iran granted emergency use permission to the domestic vaccine COVIRAN Bereket developed against coronavirus (Covid-19) on June 14.